Venera Emruli
Team Leader & Senior Scientist Strike Pharma
Dr. Venera Emruli has a Ph.D. in Immunotechnology from Lund University and has over 10 years of experience in translational medicine, biomarker discovery and oncology drug development. In her current role as Team Leader and Senior Scientist at Strike Pharma, she leads company’s research activities in developing the next generation of CAR therapies, leveraging a proprietary, adaptable technology for targeted delivery of lipid nanoparticles.
Seminars
Thursday 26th February 2026
Advancing In-Vivo CAR-T Therapies through Adaptable Lipid Nanoparticle Delivery
4:00 pm
- Explore a novel platform enabling adaptable lipid nanoparticle (LNP) delivery for in-vivo CAR-T applications
- Discuss how merging antibody and LNP technologies enhances targeting precision and delivery efficiency
New Data
